DXR
Daxor Corporation
10.60$
-3.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 14 | Q4 14 | Q2 15 | Q4 15 | Q2 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.8% | -21.9% | -39.6% | -30.7% | -4.9% | -46.9% | +100.0% | +0.0% | -0.3% | -16.6% | +0.0% | -56.3% | +100.0% | -51.9% | +100.0% | 0.0% | -3.0% | – | – | – | – | – | – | – | – | – | – | -64.4% | +100.0% | -58.0% | +100.0% | -49.1% | +100.0% | -56.5% | +100.0% | +869.0% | -97.4% | +618.6% | -82.5% | |
| – | – | – | – | – | – | -100.0% | – | -50.0% | +164.9% | -29.1% | +100.0% | -100.0% | – | – | – | +0.0% | +27.5% | -23.6% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -17.3% | +4.8% | +202.4% | -64.8% | |
| – | +7.8% | -21.9% | -39.6% | -30.7% | -83.4% | +203.7% | -20.9% | +76.4% | -71.8% | +34.0% | -215.7% | – | -278.8% | – | +100.0% | -111.3% | – | -148.2% | – | – | – | – | – | – | – | – | – | -64.4% | +100.0% | -58.0% | +100.0% | -49.1% | +100.0% | -56.5% | +100.0% | +765.0% | -97.0% | -670.3% | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16.7% | -6.6% | -11.0% | +5.4% | -37.4% | -75.5% | +100.0% | -85.7% | +716.1% | -42.5% | +195.0% | -37.2% | +100.0% | -43.8% | +100.0% | -78.7% | +554.8% | -86.6% | +645.0% | – | – | – | – | – | – | – | – | -0.9% | +100.0% | -69.8% | +100.0% | -85.2% | +100.0% | -63.6% | +100.0% | +114.3% | -58.8% | – | – | |
| – | -30.7% | +94.5% | -12.8% | -65.4% | -68.6% | -93.5% | +2,831.4% | -94.8% | +1,839.8% | -94.8% | +2,523.1% | -93.9% | +403.0% | -77.7% | +304.1% | -89.5% | +2,994.5% | -89.3% | +3,126.7% | – | – | – | – | – | – | – | – | +80.7% | +100.0% | -77.9% | +100.0% | -47.3% | -68.9% | -63.3% | +100.0% | +231.8% | -76.5% | -3,451.6% | – | |
| – | +5.1% | -27.2% | -52.2% | -60.3% | +66.2% | -23.5% | +100.0% | +47.6% | -35.5% | -72.2% | +100.0% | -75.2% | +100.0% | -71.9% | +100.0% | -116.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -104.9% | – | – | -112.2% | – | -134.7% | |
| – | – | – | – | – | – | -95.0% | +4,944.5% | -93.1% | +1,353.1% | -96.4% | +3,719.7% | -96.7% | +511.6% | -81.9% | +1,223.7% | -93.2% | +2,391.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -73.5% | – | |
| – | – | – | – | – | -112.3% | – | – | – | – | – | – | – | – | – | +100.0% | -206.1% | – | – | – | – | – | – | – | – | – | – | – | – | +100.0% | -121.7% | – | – | +100.0% | -124.6% | – | – | -117.1% | – | -134.7% | |
| – | – | – | +191.4% | -96.9% | -160.4% | – | +100.0% | +121.3% | +9.6% | -1,087.3% | – | -98.3% | +100.0% | -73.4% | +100.0% | -150.0% | – | – | – | – | – | – | – | – | – | – | – | – | +100.0% | -117.5% | – | – | +100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | -111.4% | – | – | – | – | – | – | – | – | – | +100.0% | -206.9% | – | – | – | – | – | – | – | – | – | – | – | – | +100.0% | -121.7% | – | – | +100.0% | -124.6% | – | – | -117.1% | – | -134.7% | |
| – | +5.1% | -27.2% | -52.2% | -60.3% | -578.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -135.1% | – | – | +63.9% | -99.9% | -78,192.6% | – | – | – | -134.7% |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.